Clincosm LogoSign in Get a demo

metastatic pancreatic adenocarcinoma

Showing 26 - 50 of 71
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Pancreatic Adenocarcinoma Trial in France (Gemcitabine, Paclitaxel)

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • Bayeux, France
  • +25 more
May 17, 2022

Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Trial in

Not yet recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +6 more
  • Biopsy
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Apr 26, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Aldesleukin
  • +9 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

Metastatic Pancreatic Adenocarcinoma Trial in United States (BBI608, Nab-paclitaxel, Gemcitabine)

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • Phoenix, Arizona
  • +11 more
Apr 4, 2022

Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Charlottesville (EGFR BATs after

Recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • Metastatic Pancreatic Adenocarcinoma
  • EGFR BATs after standard of care chemo
  • Charlottesville, Virginia
    University of Virginia
Mar 30, 2022

Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Tumor, Metastatic Neuroendocrine Carcinoma Trial in United

Recruiting
  • Metastatic Lung Small Cell Carcinoma
  • +16 more
  • Phoenix, Arizona
  • +10 more
Mar 25, 2022

Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Atlanta, Georgia
  • +2 more
Feb 28, 2022

Metastatic Pancreatic Adenocarcinoma Trial (Ivaltinostat, Capecitabine)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • (no location specified)
Feb 10, 2022

Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta (Siltuximab, Spartalizumab)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Siltuximab
  • Spartalizumab
  • Atlanta, Georgia
  • +2 more
Feb 1, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +2 more
  • CXCR4 Antagonist BL-8040
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2022

Metastatic Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Inoperable Disease Trial in Denmark, Germany

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Aalborg, Denmark
  • +3 more
Dec 28, 2021

Metastatic Pancreatic Adenocarcinoma, Refractory Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +2 more
  • Nivolumab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Dec 16, 2021

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 15, 2021

Metastatic Pancreatic Adenocarcinoma Trial in United States (PEGPH20, Oxaliplatin, Leucovorin)

Active, not recruiting
Has Results
  • Metastatic Pancreatic Adenocarcinoma
  • Anchorage, Alaska
  • +153 more
Nov 29, 2021

Metastatic Pancreatic Adenocarcinoma, Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in United States (90Y-hPAM4,

Withdrawn
  • Metastatic Pancreatic Adenocarcinoma
  • +2 more
  • Gilbert, Arizona
  • +23 more
Aug 12, 2021

Metastatic Pancreatic Adenocarcinoma Trial in Madrid (nab-paclitaxel, gemcitabine, m-FOLFOX)

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • Madrid, Spain
    Spanish Cooperative for Digestive Tumour Therapy (TTD)
Aug 11, 2021

Metastatic Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Chicago, Illinois
  • +4 more
Jun 10, 2021

Metastatic Pancreatic Adenocarcinoma Trial in United States (Glufosfamide, Fluorouracil)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Corona, California
  • +21 more
May 6, 2021

Metastatic Pancreatic Adenocarcinoma Trial in San Francisco, Portland (Ibrutinib, Paclitaxel, Gemcitabine)

Completed
Has Results
  • Metastatic Pancreatic Adenocarcinoma
  • San Francisco, California
  • +1 more
Apr 13, 2021

Metastatic Pancreatic Adenocarcinoma Trial in Scottsdale, Baltimore (metformin alone (Arm A), metformin (Arm B), rapamycin (Arm

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • metformin alone (Arm A)
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Apr 9, 2021

Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Gemcitabine, Taxotere, Xeloda)

Completed
Has Results
  • Metastatic Pancreatic Adenocarcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 9, 2021

Metastatic Pancreatic Adenocarcinoma Trial in Montpellier (GEMBRAX, FOLFIRINOX)

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • Montpellier, France
    Institut regional du Cancer - Val d Aurelle
Dec 30, 2020

Metastatic Pancreatic Adenocarcinoma Trial in France (Arm A - Olaparib, ARM B - durvalumab plus selumetinib, ARM C FOLFIRI)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Arm A - Olaparib
  • +2 more
  • Avignon, France
  • +28 more
Dec 29, 2020

Metastatic Pancreatic Adenocarcinoma Trial in Worldwide (Ibrutinib, Gemcitabine, Nab-paclitaxel)

Completed
Has Results
  • Metastatic Pancreatic Adenocarcinoma
  • Huntsville, Alabama
  • +85 more
Dec 7, 2020

Metastatic Pancreatic Adenocarcinoma, BRAF Mutated Melanoma Trial in Worldwide (MEK162, AMG 479)

Terminated
  • Metastatic Pancreatic Adenocarcinoma
  • BRAF Mutated Melanoma
  • Boston, Massachusetts
  • +8 more
Dec 9, 2020